COA/RT-2026-127Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
Retatrutide 20 mg
RT-2026-127Lot 26102702Analyzed November 14, 2026
Timeline
Ordered
November 6, 2026
Received
November 13, 2026
Analyzed
November 14, 2026
Sample
Name
Retatrutide 20 mg
Expected
Retatrutide
Amount
1 vial, lyophilized powder
Testing
Client
Torello
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
23.74mg
Label claim: 20 mg
Purity, how clean it is
>99.9%
Measured, not estimated. Purity is calculated from the full chromatogram shown above, and no impurity peaks were detected above the reporting threshold. Results of 99.95% or higher are reported as >99.9%, as 100% purity cannot be demonstrated analytically.
Chromatogram
HPLC-UV
18.16 min, Retatrutide, >99.9%
Analyst Comments
White lyophilized powder, unlabeled purple-cap vial, received sealed.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 14, 2026
Verification Code
RT-ON23-2USQ
Verify at purilab.org/verify/RT-ON23-2USQ
Scan to Verify
RT-ON23-2USQ
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1